BioCentury | Aug 1, 2020
Emerging Company Profile
VIB spinout ExeVir targeting COVID-19 with single-domain antibody technology
...by Fund+, will pursue therapies for COVID-19. Ablynx N.V. was the first company formed by Flanders Institute for Biotechnology (VIB)...
...for Biotechnology and Ghent University (VIB-UGent) Disease focus: Infectious Clinical status: Preclinical Founded: 2020 by Flanders Institute for Biotechnology (VIB)...
...Mummenbrauer Patents: None Targets vWF - von Willebrand factor Danielle Golovin, Staff Writer Cablivi, anti-vWF Nanobody, caplacizumab (ALX-0081/ALX-0681) Flanders Institute for Biotechnology (VIB) UCB...
...for Biotechnology and Ghent University (VIB-UGent) Disease focus: Infectious Clinical status: Preclinical Founded: 2020 by Flanders Institute for Biotechnology (VIB)...
...Mummenbrauer Patents: None Targets vWF - von Willebrand factor Danielle Golovin, Staff Writer Cablivi, anti-vWF Nanobody, caplacizumab (ALX-0081/ALX-0681) Flanders Institute for Biotechnology (VIB) UCB...